New pill aims to protect Diabetics' eyesight
NCT ID NCT07199777
Summary
This study is testing whether an oral medication called SNP318 can safely reduce fluid buildup in the retina and improve vision for people with diabetic macular edema (DME). About 60 participants will take either the drug or a placebo pill daily for 12 weeks, followed by a 4-week monitoring period. The goal is to see if this pill can control the eye disease and potentially offer an alternative to eye injections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.